Quantum Genomics (Alternext – FR0011648971 – ALQGC), a biopharmaceutical company with the mission of developing new therapies for unmet medical needs in the field of cardiovascular diseases, announces announces its financial results for the first half of the year, ended 30 June 2015 and events after the reporting period and recent news.
[button link=”http://www.quantum-genomics.com/www/wp-content/uploads/2015/10/QGC_PR_Résultats-semestriels-2015_20151015_VDEF_EN.pdf” target=”_blank” title=”Download Press Release” size=”small” color=”red”]
